-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Alnylam Pharmaceuticals (NASDAQ:ALNY) Receives “Buy” Rating from Needham & Company LLC
Needham & Company LLC reiterated their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a report released on Wednesday,Benzinga reports. Needham & Company LLC currently has a $320.00 price objective on the biopharmaceutical company’s stock. A number of other analysts have also commented on the company. Royal Bank of Canada reissued […]
Needham & Company LLC reiterated their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a report released on Wednesday,Benzinga reports. Needham & Company LLC currently has a $320.00 price objective on the biopharmaceutical company’s stock. A number of other analysts have also commented on the company. Royal Bank of Canada reissued […]
